Mölnlycke Health Care US, LLC, is pleased to announce the newest product addition: Mepilex® Border Ag antimicrobial bordered foam dressing with Safetac® technology.
NORCROSS, GA – November 11, 2010 - Mölnlycke Health Care US, LLC, is pleased to announce the newest product addition: Mepilex® Border Ag antimicrobial bordered foam dressing with Safetac® technology.
Mepilex® Border Ag represents the next generation of innovative antimicrobial wound dressings offering a comprehensive, all-in-one dressing that effectively absorbs and retains exudate and maintains a moist wound environment. Mepilex® Border Ag has powerful silver performance that inactivates wound related pathogens within 30 minutes and sustains antimicrobial effect for up to 7 days.
The Safetac® layer seals the wound edges, which allows exudate to pass into the absorbent core and minimizes the risk of maceration. Mepilex® Border Ag features a multi-layered absorbent foam pad consisting of a unique compressed foam with silver and a fiber layer for maximum fluid retention. This combination absorbs, spreads and retains exudate while allowing the silver to be released. Mepilex® Border Ag is ideal for medium to high exuding wounds that require a moist environment, exudate management, gentle fixation, and antimicrobial action, including leg and foot ulcers pressure ulcers, superficial and partial thickness burns, traumatic wounds, and surgical wounds.
Mepilex® Border Ag may be left in place for up to 7 days, depending on the condition of the wound, which reduces the necessity for frequent primary dressing changes.
Mölnlycke Health Care is one of the world’s leading providers of single-use surgical and wound care solutions to the professional health care sector.
For more information about Mölnlycke Health Care and our full line of products, please visit our websites at www.molnlycke.us or www.mhcwoundcare.com; email us at email@example.com or contact our customer service department at 1-800-882-4582.